astragaloside a has been researched along with Cardiovascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; He, Q; Jiang, F; Lu, X; Meng, P; Yang, R; Yang, T | 1 |
| Cheng, Z; Feng, J; Guo, H; Li, P; Liu, B; Qin, W; Shao, S; Wan, M; Xu, Z; Xue, W; Zhang, Y; Zhou, H | 1 |
| Chen, HW; Li, J; Tan, YQ | 1 |
| Qi, R; Tuerdi, N; Wan, Y; Wang, Y; Xu, L; Ye, M | 1 |
| Cao, Z; Ding, H; Li, F; Rui, Y; Tao, L; Yang, P; Zhang, W; Zhao, J | 1 |
3 review(s) available for astragaloside a and Cardiovascular Diseases
| Article | Year |
|---|---|
Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress.
Topics: Animals; Cardiovascular Diseases; Endothelium, Vascular; Humans; Oxidative Stress; Saponins; Triterpenes | 2021 |
Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV.
Topics: Cardiovascular Diseases; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Saponins; Triterpenes | 2023 |
Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases.
Topics: Astragalus propinquus; Cardiovascular Diseases; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Molecular Conformation; Saponins; Triterpenes | 2020 |
2 other study(ies) available for astragaloside a and Cardiovascular Diseases
| Article | Year |
|---|---|
Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome.
Topics: Animals; Cardiovascular Diseases; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Fibroblasts; Fibrosis; Heart; Humans; Inflammasomes; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sapogenins; Saponins; Triterpenes | 2018 |
Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis.
Topics: Binding Sites; Cardiovascular Diseases; Computational Biology; Cytoprotection; Doxorubicin; Drug Approval; Humans; Molecular Docking Simulation; Molecular Targeted Therapy; Myocytes, Cardiac; Protein Conformation; Protein Interaction Mapping; Reproducibility of Results; Saponins; Signal Transduction; Triterpenes; United States; United States Food and Drug Administration | 2012 |